Title:
|
Correlation between previous antibiotic exposure and COVID-19 severity: a population-based cohort study
|
Author:
|
Llor, Carla; Ouchi, Dan; Giner-Soriano, Maria; Garcia-Sangenis, Ana; Bjerrum, Lars; Morros, Rosa
|
Other authors:
|
[Llor C] Fundació Institut Universitari per la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Department of Public Health, General Practice, University of Southern Denmark, Odense, Denmark. [Ouchi D, Giner-Soriano M] Fundació Institut Universitari per la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [García-Sangenís A] Fundació Institut Universitari per la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. [Bjerrum L] Section and Research Unit of General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. [Morros R] Fundació Institut Universitari per la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Plataforma SCReN, IICEC IDIAP Jordi Gol, Barcelona, Spain; IDIAP Jordi Gol |
Abstract:
|
Resistencia a los medicamentos; Atención primaria; COVID-19; Agentes antibacterianos |
Abstract:
|
Drug resistance; Primary health care; COVID-19; Anti-bacterial agents |
Abstract:
|
Resistència als fàrmacs; Atenció primària; COVID-19; Agents antibacterians |
Abstract:
|
We examined the correlation between previous antibiotic exposure and COVID-19 severity using a population-based observational matched cohort study with patient level data obtained for more than 5.8 million people registered in SIDIAP in Catalonia, Spain. We included all patients newly diagnosed with COVID-19 from March to June 2020 and identified all their antibiotic prescriptions in the previous two years. We used a composite severity endpoint, including pneumonia, hospital admission and death due to COVID-19. We examined the influence of high antibiotic exposure (>4 regimens), exposure to highest priority critically important antimicrobials (HPCIA) and recent exposure. Potential confounders were adjusted by logistic regression. A total of 280,679 patients were diagnosed with COVID-19, 146,656 of whom were exposed to at least one antibiotic course (52.3%) during the preceding two years. A total of 25,222 presented severe COVID-19 infection (9%), and the risk of severity was highest among those exposed to antibiotics (OR 1.12; 95% CI: 1.04–1.21). Among all individuals exposed to antibiotics, high, recent and exposure to HPCIAs were correlated with increased COVID severity (OR 1.19; 95% CI: 1.14–1.26; 1.41; 95% CI: 1.36–1.46; and 1.35; 95% CI: 1.30–1.40, respectively). Our findings confirm a significant correlation between previous antibiotic exposure and increased severity of COVID-19 disease. |
Subject(s):
|
-COVID-19 (Malaltia) -Antibiòtics -DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections -CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents -DISCIPLINES AND OCCUPATIONS::Natural Science Disciplines::Mathematics::Statistics as Topic::Correlation of Data -ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus -COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos -DISCIPLINAS Y OCUPACIONES::disciplinas de las ciencias naturales::matemáticas::estadística como asunto::correlación de datos |
Rights:
|
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
|
Document type:
|
Article Article - Published version |
Published by:
|
MDPI
|
Share:
|
|